drugset / Trial / NCT01923844

Effects of Bolus Surfactant Therapy on Peripheral Perfusion Index and Tissue Carbon Monoxide

NCT01923844

Phase 4 Completed 48 enrolled Ege University
RandomizedParallel-groupSingle-blindBasic science

Summary

Exogenous bolus surfactant administration may affect hemodynamic parameters and peripheral perfusion. Surfactant therapy is commonly used for respiratory distress syndrome in premature infants, which is also associated with inflammation. There are different types and doses of surfactant preparations available. With the help of new generation monitors, changes in peripheral perfusion and transcutaneous CO, a marker of inflammation, may be demonstrated.

Timeline

Start
2012-03
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Beractant Other / unclassified 100 mg/kg
Subject Poractant alfa Other / unclassified 200 mg/kg